GLP-1 RA compared to DPP4 treatment was associated with fewer alcohol-related episodes (hospital contacts or treatment for AUD, used as a surrogate for self-reported alcohol use) in the first 3 months of treatment (Hazard ratio 0.46 (95%CI: 0.24–0.86). Here, GLP1R is linked to alcohol drinking.